(FILES) In this file photo taken on April 8, 2020 one vial of the drug Remdesivir lies during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany, amidst the new coronavirus COVID-19 pandemic.

 The experimental drug remdesivir has been authorized by US regulators for emergency use against COVID-19, President Donald Trump announced on May 1, 2020. / AFP / POOL / Ulrich Perrey
In this file photo taken on April 8, 2020 one vial of the drug Remdesivir lies during a press conference at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany. AFP

Washington approves virus drug as US states ease lockdowns




View from DC

The inside scoop from The National’s Washington bureau

      By signing up, I agree to The National's privacy policy
      View from DC